Waverley Pharma Inc. 5GZ.F Stock
Waverley Pharma Inc. Price Chart
Waverley Pharma Inc. 5GZ.F Financial and Trading Overview
| Waverley Pharma Inc. stock price | 0.0090 EUR |
| Previous Close | 0.02 EUR |
| Open | 0.02 EUR |
| Bid | 0.02 EUR x N/A |
| Ask | 0.03 EUR x N/A |
| Day's Range | 0.02 - 0.02 EUR |
| 52 Week Range | 0.01 - 0.07 EUR |
| Volume | 3K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 1.31M EUR |
| Beta (5Y Monthly) | 1.328523 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
5GZ.F Valuation Measures
| Enterprise Value | 1.52M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.2316601 |
| Price/Book (mrq) | 1.1428572 |
| Enterprise Value/Revenue | 1.428 |
| Enterprise Value/EBITDA | -1.666 |
Trading Information
Waverley Pharma Inc. Stock Price History
| Beta (5Y Monthly) | 1.328523 |
| 52-Week Change | -76.81% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.07 EUR |
| 52 Week Low | 0.01 EUR |
| 50-Day Moving Average | 0.02 EUR |
| 200-Day Moving Average | 0.02 EUR |
5GZ.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 54M |
| Float | 13.61M |
| Short Ratio | N/A |
| % Held by Insiders | 74.79% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -65.24% |
| Operating Margin (ttm) | -102.66% |
| Gross Margin | 21.60% |
| EBITDA Margin | -85.71% |
Management Effectiveness
| Return on Assets (ttm) | -24.089% |
| Return on Equity (ttm) | -59.13% |
Income Statement
| Revenue (ttm) | 1.06M EUR |
| Revenue Per Share (ttm) | 0.02 EUR |
| Quarterly Revenue Growth (yoy) | -60.89% |
| Gross Profit (ttm) | N/A |
| EBITDA | -909987 EUR |
| Net Income Avi to Common (ttm) | -692644 EUR |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 135.12K EUR |
| Total Cash Per Share (mrq) | 0.003 EUR |
| Total Debt (mrq) | 786.86K EUR |
| Total Debt/Equity (mrq) | 105.31 EUR |
| Current Ratio (mrq) | 0.314 |
| Book Value Per Share (mrq) | 0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -470181 EUR |
| Levered Free Cash Flow (ttm) | -593284 EUR |
Profile of Waverley Pharma Inc.
| Country | Germany |
| State | MB |
| City | Winnipeg |
| Address | 4-1250 Waverley Street |
| ZIP | R3T 6C6 |
| Phone | 204-928-7907 |
| Website | https://www.waverleypharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes cancer therapeutics in the United Kingdom. It focuses on the generic oncology injectable products. The company sells generic oncology products comprising capecitabine, temozolomide, and erlotinib. Its products under development include injectable generic chemotherapy drugs, such as Pemetrexed for the treatment of non-small cell lung cancer and other indications; and Bortezomib to treat multiple myeloma and other indications. Waverley Pharma Inc. is headquartered in Winnipeg, Canada.
Q&A For Waverley Pharma Inc. Stock
What is a current 5GZ.F stock price?
Waverley Pharma Inc. 5GZ.F stock price today per share is 0.0090 EUR.
How to purchase Waverley Pharma Inc. stock?
You can buy 5GZ.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Waverley Pharma Inc.?
The stock symbol or ticker of Waverley Pharma Inc. is 5GZ.F.
Which industry does the Waverley Pharma Inc. company belong to?
The Waverley Pharma Inc. industry is Biotechnology.
How many shares does Waverley Pharma Inc. have in circulation?
The max supply of Waverley Pharma Inc. shares is 81.1M.
What is Waverley Pharma Inc. Price to Earnings Ratio (PE Ratio)?
Waverley Pharma Inc. PE Ratio is now.
What was Waverley Pharma Inc. earnings per share over the trailing 12 months (TTM)?
Waverley Pharma Inc. EPS is -0.03 EUR over the trailing 12 months.
Which sector does the Waverley Pharma Inc. company belong to?
The Waverley Pharma Inc. sector is Healthcare.